Morepen Laboratories Ltd share price logo

Morepen Laboratories Ltd

NSE: MOREPENLAB

BSE: 500288

Small Cap

Pharma Sector

₹109.90

+3.68

(+3.46%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Morepen Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+149%

Searches for Morepen Laboratories on INDmoney have increased by 149% over the last 30 days.

Investment activity on INDmoney

+67.79%

Investment activity in Morepen Laboratories among INDmoney users has increased by 67.79% over the last 30 days.

Among the most traded stocks

41st

Morepen Laboratories was the 41st most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

35 days

INDmoney investors hold Morepen Laboratories shares for an average of 35 days.

Key Events for Morepen Laboratories

Upcoming Events

Ex-Dividend Date18/09/2026
Record Date19/09/2026

Last Dividend Declared

₹0.20 per share, declared on 26/05/2026

View Dividend History

Morepen Laboratories Stock Performance

as on September 16, 2026 at 5:46 pm IST

  • Day's Low

    Day's High

    ₹97.04
    ₹111.30
    downward going graph

    11.70%

    Downside

    1.27%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹33.05
    ₹122.55
    downward going graph

    69.93%

    Downside

    11.51%

    Upside

    downward going graph

Morepen Laboratories share price movements today

Previous Close
₹106.22
Open
₹109.82
Volume
2.52Cr
Upper Circuit
₹116.84
Lower Circuit
₹95.60
Day's Low - High
₹97.04 - ₹111.30
52 Week Low - High
₹33.05 - ₹122.55

Morepen Laboratories Historical Returns

1 Month Return
+ 18.26 %
3 Month Return
+ 103.18 %
1 Year Return
+ 99.17 %
3 Year Return
+ 185.54 %
5 Year Return
+ 83.61 %

Morepen Laboratories Fundamentals

as on September 16, 2026 at 12:16 pm IST

Market Cap

₹5,820.36 Cr

Return on Equity (ROE)

5.45

PE Ratio (TTM)

45.23

Return on capital employed (ROCE)

7.2

Industry PE ratio

51.81

Beta (LTM)

1.46

P/B Ratio

1.49

Dividend Yield

0.59

PEG Ratio

51.98

Quarterly Earnings Growth YOY

393.87

EPS (TTM)

1.75

Book Value

22.75

Morepen Laboratories Stock Valuation

as on September 16, 2026 at 12:16 pm IST

Morepen Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (10.48x)

March 23, 2020

Today (45.23x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (64.70x)

January 22, 2018

LowHigh

Today’s Price to Earnings Ratio: 45.23x

Morepen Laboratories Technical Analysis

Track how Morepen Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish13
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
0.27
Bearish
CCI (20)
-545.78
Bullish
RSI (14)
64.82
Neutral
Momentum (10)
0.26
Bullish
ADI (14)
33.54
Bullish
Ultimate Oscillator (7,14,28)
89.3
Bullish

Moving Averages

Name

Value

Action

SMA (20)
109.79
Bullish
EMA (20)
109.73
Bullish
VWMA (20)
109.89
Bullish
SMA (50)
109.1
Bullish
EMA (50)
109.26
Bullish
SMA (200)
105.93
Bullish
EMA (200)
107.53
Bullish
KAMA (200)
109.01
Bullish
DEMA (200)
108.4
Bullish

Morepen Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Morepen Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Morepen Laboratories Ltd image
Morepen Laboratories Ltd
NA5,820.3616.72%0.58951,805
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Morepen Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
421.77
444.55
423.07
455.22
437.73
452.78
465.85
425.24
411.58
484.16
484.72
570.13
Other Income
3.24
4.07
4.24
3.43
4.99
5.34
4.61
4.41
30.46
3.81
8.46
5.18
Total Income
425.01
448.62
427.32
458.64
442.71
458.12
470.46
429.65
442.04
487.97
493.18
575.31
Expenses
388.18
393.99
374.69
403.6
393.66
416.64
423.61
401.07
380.88
437.84
460.27
487.59
Operating Profit
33.59
50.56
48.38
51.62
44.07
36.14
42.24
24.17
30.7
46.32
24.45
82.54
Operating Profit Margin %
7.96%
11.37%
11.44%
11.34%
10.07%
7.98%
9.07%
5.68%
7.46%
9.57%
5.04%
14.48%
Profit Before Interest, Tax and Depreciation
36.83
54.64
52.62
55.05
49.06
41.48
46.85
28.58
61.16
50.12
32.91
87.72
Interest
0.46
2.17
0.8
1.15
1.18
1.34
4.67
4.04
4.18
4.32
3.88
4.84
Depreciation
7.69
8.45
9.62
5.73
1.86
4.93
16.47
9.03
11.28
10.38
5.75
8.35
Profit Before Tax
28.68
44.02
42.2
48.17
46.02
35.21
25.71
15.51
45.7
35.42
23.28
74.53
Tax Paid
7.43
12.03
13.46
12
11.17
8.52
5.41
4.11
4.65
7.93
7.59
18.18
Profit After Tax
21.26
31.99
28.74
36.17
34.85
26.69
20.31
11.41
41.04
27.5
15.7
56.35
Total Net profit including share of profit / Loss from associate company
21.26
31.99
28.74
36.17
34.85
26.69
20.31
11.41
41.04
27.5
15.7
56.35
EPS
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03
Actual EPS
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03
Adjusted EPS
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03
Diluted EPS
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
0.5
0.28
1.03

Morepen Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
606.51
768.54
853.07
1,188.06
1,546.83
1,417.53
1,690.43
1,811.58
1,805.69
Other Income
3.72
3.67
9.48
12.07
10.31
6.13
13.97
18.36
47.14
Total Income
610.23
772.21
862.55
1,200.13
1,557.13
1,423.66
1,704.4
1,829.94
1,852.83
Expenses
541.96
701.02
784.55
1,069.54
1,410.15
1,338
1,531.81
1,637.51
1,680.06
Operating Profit
64.55
67.52
68.52
118.52
136.68
79.53
158.62
174.07
125.63
Operating Profit Margin %
10.64%
8.79%
8.03%
9.98%
8.84%
5.61%
9.38%
9.61%
6.96%
Profit Before Interest, Tax and Depreciation
68.27
71.19
78
130.58
146.98
85.67
172.6
192.43
172.77
Interest
4.36
2.11
1.98
1.79
-7.37
1.98
3.71
8.34
16.41
Depreciation
34.32
39.9
36.91
30.28
27.64
27.93
33.47
28.98
36.43
Profit Before Tax
29.59
29.18
39.11
98.51
126.71
55.76
135.42
155.11
119.93
Tax Paid
-
0.34
5.53
1.42
25.02
17.08
38.79
37.1
24.28
Profit After Tax
29.59
28.84
33.58
97.09
101.68
38.68
96.62
118.02
95.65
Total Net profit including share of profit / Loss from associate company
29.59
28.84
33.58
97.09
101.68
38.68
96.62
118.02
95.65
EPS
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
1.73
Actual EPS
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
1.73
Adjusted EPS
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
1.73
Diluted EPS
0.66
0.64
0.75
2.15
1.96
0.77
1.88
2.2
1.73

Morepen Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
50.07
40.73
63.41
17.37
11.02
50.83
-60.24
-91.17
73.37
32.06
32.64
Cash Flow from Investing Activities
-27.3
-13.6
-26.92
-13.05
-12.46
-70.35
-31.68
-46.51
-83.31
-321.51
-126.24
Cash Flow from Financing Activities
-27.26
-23.72
-37.78
-0.44
5.49
47.26
66.33
143.54
5.2
299.88
97.41
Net Cash Flow
-4.49
3.4
-1.29
3.88
4.04
27.75
-25.58
5.86
-4.72
10.44
3.81

Morepen Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
38.22%
38.22%
38.22%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
DII
2%
2.15%
2.15%
2.9%
1.7%
1.64%
1.68%
1.51%
1.5%
1.25%
1.25%
1.28%
FII
0%
1.85%
1.67%
7.72%
2.08%
2.22%
1.94%
1.72%
1.62%
1.62%
1.58%
1.46%
Government
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
57.44%
57.77%
57.95%
53.72%
60.56%
60.47%
60.72%
61.11%
61.21%
61.46%
61.5%
61.59%
Total Outstanding Shares
51,11,68,708
51,11,68,708
51,11,68,708
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
Total Shareholders
3,04,289
3,36,019
3,48,766
3,52,839
4,30,929
4,48,361
4,68,860
4,61,180
4,61,853
4,53,137
4,47,286
4,34,912

Mutual Funds Buying / Exiting Morepen Laboratories

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Morepen Laboratories

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.06 Cr

₹0.00 Cr (+3.72%)

0.12%

Mutual Funds Exiting Morepen Laboratories

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Morepen Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Morepen Laboratories.

  • Morepen Laboratories Ltd Earnings Results

    Morepen Laboratories Ltd’s net profit jumped 424.65% since last year same period to ₹56.40Cr in the Q1 2026-2027. On a quarterly growth basis, Morepen Laboratories Ltd has generated 258.32% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Morepen Laboratories Ltd Dividends May,2026

    In the quarter ending March 2026, Morepen Laboratories Ltd has declared dividend of ₹0.20 per share on 26 May 2026 - translating a dividend yield of 0.17%.

    Read More about Dividends

Indices Featuring Morepen Laboratories Stock

Check stock indices that include Morepen Laboratories.

BSE Healthcare

₹50,216.22

-262.59 (▲0.52%)

Insights on Morepen Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MOREPENLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 15.74 Cr → 56.4 Cr (in ₹), with an average increase of 72.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 429.65 Cr → 575.31 Cr (in ₹), with an average increase of 6.9% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 61.50% to 61.59% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MOREPENLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 35.65% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.59% to 1.46% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MOREPENLAB stock has moved down by -8.9%

About Morepen Laboratories Ltd

Morepen Laboratories Limited is a pharmaceutical company based in India that develops and markets formulation products in numerous therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic, and neuropsychiatry. Their products include Loratadine Montelukast Sodium, Atorvastatin Calcium and Sultamicillin, along with new entries such as Kilbac Ducal, D Aclomore and Montelast-L. It currently has three state-of-the-art manufacturing plants in Himachal Pradesh, India, with the main plant in Parwanoo being USFDA-approved for Loratadine production. The company was established in 1984 and since then has filed 14 patents, including an international one on a new amorphous form of Lipitor Atorvastatin. Expansion plans from 1992-1993 saw the installation of bulk drugs from 162 MT to 245 MT and the launch of two new molecules – Ketrolac, Tromethamine and Omeprazole. In 1995-1996, the company increased bulk drug installation from 305 MT to 469 MT and launched Loratadine and Cisapride. The year 1996-1997 saw the commencement of their own formulation unit, while they filed an international patent on a new amorphous form of Atorvastatin, world’s largest selling drug in 2000-2001. In 2001-2002, their drug and drug intermediate installation reached 1251 MT, with the launch of a number of contemporary lifestyle and self-medication products. Their joint venture with DiaMed AG of Switzerland was among the highlights of the year 2004-2005, while 2006-2007 saw them acquire fifty new prospective customers in Korea, Japan and Taiwan. The year 2007-2008 was marked by the company making tie-ups with several new business segments, along with marketing alliances with global players such as Immucor USA, Teco Medical Instruments, and In-Tech, INC.

Revenue: ₹570.13Cr as on June 2026 (Q1 FY27)
Net Profit: ₹56.35Cr as on June 2026 (Q1 FY27)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
OrganisationMorepen Laboratories Ltd
HeadquartersGurgaon
IndustryPharmaceuticals
CEOSushil Suri
E-voting on sharesClick here to vote

FAQs

What is Morepen Laboratories share price today?

Morepen Laboratories share price today stands at ₹109.9 as on . Morepen Laboratories share today touched a day high of ₹111.3 and a low of ₹97.04.

What is the 52 week high and 52 week low range for Morepen Laboratories share?

Morepen Laboratories touched a 52 week high of ₹122.55 and a 52 week low of ₹33.05. Morepen Laboratories share price today i.e. is trending at ₹109.9, which is -10.32% down from its 52 week high and 232.53% up from its 52 week low.

What is Morepen Laboratories's market capitalisation today?

Morepen Laboratories market capitalisation is ₹5,820.36 Cr as on .

How to buy Morepen Laboratories shares?

To buy Morepen Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MOREPENLAB or Morepen Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Morepen Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Morepen Laboratories trading volume today?

Morepen Laboratories trading volume is 2.52Cr as on . This means that 2.52Cr shares of Morepen Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Morepen Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Morepen Laboratories have both increased over the past 30 days, and the average INDmoney investor holds the stock for 35 days. This reflects platform activity only and is not investment advice.